“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database
Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.
New clinical trials added on Mar 24, 2023
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
NCT Number : NCT05775146
Cancer Survivorship in Hematologic Malignancies
NCT Number : NCT05780411
Improving Access to Lung Cancer Clinical Trials
NCT Number : NCT05780164
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
NCT Number : NCT05774951
Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression
NCT Number : NCT05779553
Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences
NCT Number : NCT05778045
Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
NCT Number : NCT05780567
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
NCT Number : NCT05776524
Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer
NCT Number : NCT05777603
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm
NCT Number : NCT05779631
Implantable Microdevice for TNBC - Pilot Study
NCT Number : NCT05774886
A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer
NCT Number : NCT05775549
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
NCT Number : NCT05780307
Lung Cancer, Exercise and Force Development
NCT Number : NCT05778136
Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors
NCT Number : NCT05775406
Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation
NCT Number : NCT05774678
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
NCT Number : NCT05776147
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
NCT Number : NCT05775471
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
NCT Number : NCT05775159
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer
NCT Number : NCT05779943
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
NCT Number : NCT05778149
UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors
NCT Number : NCT05775666
Fast MRI Compared to Routine Clinical MRI in Children With Brain Tumor
NCT Number : NCT05776602
Cryoablation+Ipilimumab+Nivolumab in Melanoma
NCT Number : NCT05779423
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NCT Number : NCT05780684
Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)
NCT Number : NCT05778097
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
NCT Number : NCT05780034
Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC
NCT Number : NCT05775796
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
NCT Number : NCT05779163
Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
NCT Number : NCT05776979
Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients
NCT Number : NCT05778708
Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases
NCT Number : NCT05774964
IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT Number : NCT05774873
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression
NCT Number : NCT05777278
A Phase 1/2 Study CB-103 With or Without Venetoclax in Patients With NOTCH ACC
NCT Number : NCT05774899
COACH-Cog Intervention Adaptation Focus Groups
NCT Number : NCT05775991
NKG2D CAR-NK & Ovarian Cancer
NCT Number : NCT05776355
Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt
NCT Number : NCT05776758
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
NCT Number : NCT05778825
ARtificial Intelligence for Gross Tumour vOlume Segmentation
NCT Number : NCT05775068
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
NCT Number : NCT05776381
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
NCT Number : NCT05776875
Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
NCT Number : NCT05775900
PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer
NCT Number : NCT03638297
Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer
NCT Number : NCT05775822
A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer
NCT Number : NCT05775575
Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma
NCT Number : NCT05778955
Mesothelin-CAR-T Cells Against Cancers
NCT Number : NCT05779917
Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
NCT Number : NCT05775458
The Effects of Multi-Psycho-Oncology Care Courses
NCT Number : NCT05776680
THE EFFECT OF THE EDUCATION GIVEN TO DEATH CANCER PATIENTS AND THE NURSES CARING FOR THEIR FAMILIES ON NURSING CARE
NCT Number : NCT05775926
A Study of RO7247669 Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer
NCT Number : NCT05775289
Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma
NCT Number : NCT05776667
Exploratory Evaluation of the Functional/Emotional Life Characteristics During the First Year of Ongoing Endocrine Adjuvant Treatment With Aromatase Inhibitors in Breast Cancer Patients With Reduced Bone Mineral Density
NCT Number : NCT05779566
Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy
NCT Number : NCT05777824
SMC Radiation Oncology Breast Cancer Cohort Study
NCT Number : NCT05775757
Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
NCT Number : NCT05779670
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
NCT Number : NCT02112565
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
NCT Number : NCT05776407
Telerehabilitation in Hemato-oncological Survivors
NCT Number : NCT05779605
Effect of CaviionTM Precaution Medical Adhesive-related Skin Injury in Tumor Patients With PICC Catherizaion
NCT Number : NCT05776732
Clinical Trial for the Validation of AR Based Neuronavigation System
NCT Number : NCT05776706
Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment
NCT Number : NCT05774990
A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
NCT Number : NCT05775523
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung Cancer, EUCLID Trial
NCT Number : NCT05775939
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC
NCT Number : NCT05780294
A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
NCT Number : NCT05779592
Effect of Mirabegron on Promoting Brown Adipose Tissue Activation
NCT Number : NCT05779514
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT Number : NCT05780372
Prognostic and Predictive Markers of Treatment Response in Patients With Pancreatic Adenocarcinoma
NCT Number : NCT05776342
Effects of Adding Dexamethasone Plus Ketamine to Bupivacine in Serrtatus Plane Block
NCT Number : NCT05775393
Epidemiology of Helicobacter Pylori Infection in Moscow
NCT Number : NCT05775120
A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study
NCT Number : NCT05777993
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
NCT Number : NCT05775094
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma
NCT Number : NCT05777707
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
NCT Number : NCT05778253
Radiomic fEatures of Pancreas From Contrast Enhanced CT Image Predict One-Year RecUrrence Risk of Acute PancReatitis
NCT Number : NCT05778929
The Effects of Mindfulness-based Cognitive Therapy in People With Parkinson's Disease
NCT Number : NCT05779137
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
NCT Number : NCT05775874
Oxygen Nanobubble Drink Impact on Exercise in Elite Athletes
NCT Number : NCT05777642
MUSic Therapy In Complex Specialist Neurorehabilitation
NCT Number : NCT05777499
COVID-19 Infection in Patients With Hepatocellular Carcinoma
NCT Number : NCT04367805
Serratus Plain Block Versus Paravertebral Block Versus Serratus Plain Block and Paravertebral Block for Postoperative Pain Following Thoracoscopic Surgery
NCT Number : NCT04222010
Study of Different Gating Techniques for PET Image of Lung and Liver Lesions
NCT Number : NCT05779865
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
NCT Number : NCT05775419
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment
NCT Number : NCT05780073
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
NCT Number : NCT05779930
Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population
NCT Number : NCT05778851
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
NCT Number : NCT05775705
Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis
NCT Number : NCT05776940
R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma
NCT Number : NCT05777369
Mindful Parenting - A Single Case Experimental Design Study
NCT Number : NCT05779527
Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2
NCT Number : NCT05778006
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
NCT Number : NCT05782985
Role of Surgery in Management of Pineal Region Tumors in Children
NCT Number : NCT05781984
Psychoeducation Intervention for Caregivers of Children With Cancer
NCT Number : NCT05783310
Self-collected Vaginal and Urine Samples in HIV-positive Women
NCT Number : NCT05783167
MSLN-targeted CAR-T Cells in Solid Tumors.
NCT Number : NCT05783089
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
NCT Number : NCT05781217
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
NCT Number : NCT05783323
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
NCT Number : NCT05780814
IV Ibuprofen vs Ketorolac in Post Operative Pain in Colorectal Cancer Surgeries in Obese Patient
NCT Number : NCT05782608
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
NCT Number : NCT05782361
Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC
NCT Number : NCT05782426
A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
NCT Number : NCT05781555
A Phase I Clinical Study of the Safety, Tolerability,Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors
NCT Number : NCT05781048
Open-Label, Multicenter, Phase 1/1b Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
NCT Number : NCT05783622
Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in the Primary Prevention of Catheter-related Endoluminal Infection in Paediatric Oncology
NCT Number : NCT05781295
Developing a MRI-based Deep Learning Model to Predict MMR Status
NCT Number : NCT05783986
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
NCT Number : NCT05784428
A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer
NCT Number : NCT05780736
Multi-Cancer Early Detection (MCED) of Firefighters
NCT Number : NCT05780957
Multiparametric Magnetic Resonance Imaging Performance in Detection of Occult Muscle Invasion in Urinary Bladder Cancer
NCT Number : NCT05783271
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer (CASTLE-08)
NCT Number : NCT05781074
A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia
NCT Number : NCT05780879
Advanced Data-Aided Medicine Part Lung Cancer
NCT Number : NCT05783024
The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
NCT Number : NCT05781633
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
NCT Number : NCT05782465
Epcoritamab and Rituximab for First-line Follicular Lymphoma
NCT Number : NCT05783609
Patient-centered Breast Cancer Teleprehabilitation
NCT Number : NCT05782504
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
NCT Number : NCT05783596
Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer
NCT Number : NCT04030260
SBRT Plus vNKT for Pancreatic Cancer
NCT Number : NCT05783076
A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
NCT Number : NCT05781386
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT Number : NCT00657878
A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.
NCT Number : NCT01745965
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy
NCT Number : NCT05781308
Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)
NCT Number : NCT05784142
STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
NCT Number : NCT00526396
A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma
NCT Number : NCT05783921
Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer
NCT Number : NCT01815242
A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol
NCT Number : NCT01817452
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors
NCT Number : NCT05781360
Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)
NCT Number : NCT05784311
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma (RADIAN)
NCT Number : NCT05784012
A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response
NCT Number : NCT02214381
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
NCT Number : NCT04175912
Impact of A. Lumbricoides on Pulmonary Aspergillosis Development
NCT Number : NCT05783544
Adapting a Betel Quid Cessation Program for a High-risk Community in Malaysia and Evaluating Its Effectiveness
NCT Number : NCT05782166
Prediction of Delayed Toxic Cardiomyopathy in Children
NCT Number : NCT05781672
Impact of Systematic Shaving on Margins
NCT Number : NCT05782686
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT Number : NCT05781152
Digital Voice Analysis as a Measure of Frailty and Distress
NCT Number : NCT05783401
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
NCT Number : NCT05781321
Use of Virtual Reality for Surgical Planning in Neuroblastoma
NCT Number : NCT05781919
Surgeons' Mental Distress and Risks After Severe Complications Following Radical Gastrectomy
NCT Number : NCT05782205
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
NCT Number : NCT05781581
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
NCT Number : NCT05781841
Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
NCT Number : NCT05784415
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma
NCT Number : NCT05782400
Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
NCT Number : NCT05783518
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
NCT Number : NCT05780905
Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial
NCT Number : NCT05782777
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)
NCT Number : NCT05781568
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
NCT Number : NCT05783908
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
NCT Number : NCT05783570
The Effect of Brain Breaks on People With Mental Health Problems
NCT Number : NCT05783674
Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions
NCT Number : NCT04172922
Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC
NCT Number : NCT05781958
Real World Data on Ibrutinib Use in PCNSL Rel/Ref
NCT Number : NCT05782374
Phase 1 Study of BCD-245 in Subjects With Neuroblastoma
NCT Number : NCT05782959
Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract Carcinomas
NCT Number : NCT05783973
Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma
NCT Number : NCT05783882
C-CAR066 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
NCT Number : NCT05784441
The Effectiveness and Safety of Ultrasound Elastography Guided Pleural Biopsy in the Differential Diagnosis of Benign and Malignant Pleural Effusion
NCT Number : NCT05781659
Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
NCT Number : NCT05782127
A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom
NCT Number : NCT05782764
A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
NCT Number : NCT05784129
Enter a few details below to get started and we'll help you match up with active clinical trials
8578 Trials found
Cancer Details
Eligibility Criteria
Location
OncoPower Clinical Trial Features
Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you
We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria
Our team will connect you with financial resources available to clinical trial participants
OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial
Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.
There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).
Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.
You are able to leave a clinical trial at any time, for any reason.
Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.
Joan-Smith
Virginia, United States
ChuckHastings
Florida, United States
DebraPearl
Pennsylvania, United States
Jennweeks
Iowa , United States
PatrickDW
Western Cape, South Africa
Jamie-Alexander
Floroda United States
CJ
Liz
Florida, United States
NYCynthia
New York, United States
Ferdi
California, United States
Begin offering a comprehensive digital experience for your patients.
Enter your E-mail address to receive your results